quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:41:18·56d
SECFiling
Puma Biotechnology Inc logo

SEC Form 10-K filed by Puma Biotechnology Inc

PBYI· Puma Biotechnology Inc
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • PBYI
    Puma Biotechnology Inc
    Health Care

Recent analyst ratings

  • Sep 28UpdateCitigroup$11.00
  • Sep 28UpdateCitigroup-
  • Aug 6UpdateRBC Capital$6.00
  • Aug 6UpdateGoldman Sachs$8.00

Related

  • PR14h
    Puma Biotechnology to Host Conference Call to Discuss First Quarter 2026 Financial Results
  • SEC16d
    SEC Form PRE 14A filed by Puma Biotechnology Inc
  • PR21d
    Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Puma Biotechnology Inc
  • SEC56d
    Puma Biotechnology Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR56d
    Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results
  • PR59d
    Puma Biotechnology to Present at TD Cowen's 46th Annual Health Care Conference
  • INSIDER62d
    President and CEO Auerbach Alan H was granted 159,778 shares, increasing direct ownership by 2% to 7,305,729 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022